Targeting Metabolic Vulnerability by Combining NAMPT Inhibitors and Disulfiram for Treatment of Recurrent Ovarian Cancer
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Preprint in Research Square (April 2024)
Article in Nanomedicine (April 2024)
Article in Biomicrofluidics (March 2024)